Foreign Product Alerts: Vitaccino Coffee, Collagen Slim, and Sulami

Starting date:
July 10, 2014
Posting date:
July 10, 2014
Type of communication:
Foreign Product Alert (FPA)
Subcategory:
Natural health products
Source of recall:
Health Canada
Source of alert:

U.S. Food and Drug Administration, Australian Therapeutic Goods Administration, Hong Kong Department of Health

Issue:
Undeclared Substance
Audience:
General Public
Identification number:
RA-40163

Introduction

These products are not authorized for sale in Canada and have not been found in the Canadian marketplace, but it is possible they may have been brought into the country by travellers or purchased over the Internet.

Affected products

  • Vitaccino Coffee
  • Collagen Slim
  • Sulami

Vitaccino Coffee

Product description

This product is promoted for weight loss.

Hazard identified

The U.S. Food and Drug Administration (FDA) warned consumers not to use this product after it was found to contain sibutramine.

  • Sibutramine was previously used to treat obesity but is no longer authorized for sale in Canada because of its association with an increased risk of cardiovascular side effects such as heart attack and stroke.

Place of origin

Unknown

Side effects

In addition to heart attack and stroke, side effects associated with sibutramine include increased blood pressure and heart rate, dry mouth, difficulty sleeping and constipation.

Collagen Slim

Product description

This product is promoted for weight loss.

Hazard identified

The Australian Therapeutic Goods Administration (TGA) warned consumers not to use this product after it was found to contain sibutramine.

  • Sibutramine was previously used to treat obesity but is no longer authorized for sale in Canada because of its association with an increased risk of cardiovascular side effects such as heart attack and stroke.

Place of origin

Unknown

Side effects

In addition to heart attack and stroke, side effects associated with sibutramine include increased blood pressure and heart rate, dry mouth, difficulty sleeping and constipation.

Sulami

Product description

This product is promoted for weight loss.

Hazard identified

The Hong Kong Department of Health warned consumers not to use this product after it was found to contain sibutramine and spirolactone.

  • Sibutramine was previously used to treat obesity but is no longer authorized for sale in Canada because of its association with an increased risk of cardiovascular side effects such as heart attack and stroke.
  • Spirolactone is a prescription drug used to remove excess fluid from the body and should only be taken under the supervision of a healthcare professional.

Place of origin

Unknown

Side effects

In addition to heart attack and stroke, side effects associated with sibutramine include increased blood pressure and heart rate, dry mouth, difficulty sleeping and constipation.

Side effects associated with spironolactone include electrolyte imbalance (specifically potassium), fatigue, gastrointestinal irritation, dizziness, liver and kidney damage, breast enlargement in males, and reproductive disorders.

What you should do

Health Canada advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find the products listed above in the Canadian marketplace.

Canadians who have these products are advised not to use them, and should consult with a healthcare professional if they have concerns about their health related to the use of these products.

Background

Drugs and natural health products that are authorized for sale in Canada will have an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.

As of May 15, 2014, no adverse reactions suspected to be associated with the use of these products have been reported to Health Canada.

Report a health or safety concern

To report a side effect to a health product to Health Canada:

  • Call toll-free at 1-866-234-2345
  • Visit Health Canada's Web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax

Images

Select thumbnail to enlarge - opens in a new window